IR UpFront Calendar


Dec. 10, 8 p.m. ET. Virtual SIR Virtual Angio Club hosted by the SIR Renal Clinical Specialty Council


Jan. 24—Jan 25 Atlanta Navigating the IR revenue cycle to increase your bottom line


March 29–April 2 Nashville Courtesy of the PAD Collaborative Getting a pulse on PAD


The PAD Collaborative—a collection of organizations and experts, committed to increasing public awareness and understanding of PAD, of which SIR is a founding member— has published a heat map to raise awareness about the growing amputation crisis related to peripheral artery disease. The heat map is interactive, providing data on limb illustrations per 100,000 Medicare amputees per year, by state and congressional district.


You can view the interactive heat map and corresponding toolkit via the QR codes. For more information, email SIR Director of Communications Elise Grant at egrant@sirweb.org.


Save your seat at the SIR Foundation Gala 2025!


View the


interactive heat map


Join us for an unforgettable evening at the SIR Foundation Gala 2025, happening March 30 at the Omni Nashville. Get ready for an evening filled with the vibrant energy of Music City while celebrating achievements and supporting our mission to advance IR through research and education.


Toolkit


Secure your ticket now now and make this a night to remember! sirfoundation. org/donate/events/gala/


g/donat


Nuclear Regulatory Commission issues report on radiopharmaceutical adverse events


ort on


The Nuclear Regulatory Commission (NRC) issued Information Notice 2024-04 to report on recent medical events that in olv therapeutic radiopharmaceuticals. The NRC asks that clinicianshat clinicians and authorized personnel that offer radiopharmaceutical therapies review the notice and consider training and protocols t


ormation s that involved


eutical therapies ols to avoid


oid similar medical events. Providers are reminded that medical events


involving radiopharmaceuticals should be reported to the NRC to notify other users and avoid similar adverse incidents.


t medical e ents fy other users


ev nts/gala/


11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40